In this study, numerous genetic analysis tools, such as GEPIA2, TIMER2 and UALCAN, were applied to analyze more than 10,000 samples retrieved from TCGA, GEO, GTEx and CPTAC datasets on the expression of RCC1 gene in 33 tumor entities. This evidence concerns the gene RCC1 and neoplasm.